Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 1 | $575,000 |
| Sells | 18 | $2,445,466 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 19 Nov 2024 16:05 | KURA | Kura Oncology Inc | FORD KATHLEEN | Chief Operating Officer | 18 Nov 2024 | Sale | 526 | 16.0337 | 8,434 | D |
| 20 May 2024 18:30 | KURA | Kura Oncology Inc | BAIR TERESA BROPHY | Chief Legal Officer | 20 May 2024 | Sale | 2,615 | 22.1477 | 57,916 | D |
| 31 Jan 2024 17:30 | KURA | Kura Oncology Inc | DOYLE THOMAS JAMES | SVP, Finance & Accounting | 29 Jan 2024 | Sale | 963 | 17.8005 | 17,142 | D |
| 31 Jan 2024 17:30 | KURA | Kura Oncology Inc | DOYLE THOMAS JAMES | SVP, Finance & Accounting | 29 Jan 2024 | Sale | 761 | 17.8005 | 13,546 | D |
| 31 Jan 2024 17:30 | KURA | Kura Oncology Inc | DOYLE THOMAS JAMES | SVP, Finance & Accounting | 29 Jan 2024 | Sale | 594 | 17.8005 | 10,573 | D |
| 31 Jan 2024 17:30 | KURA | Kura Oncology Inc | FORD KATHLEEN | Chief Operating Officer | 29 Jan 2024 | Sale | 1,496 | 17.8005 | 26,630 | D |
| 31 Jan 2024 17:30 | KURA | Kura Oncology Inc | BAIR TERESA BROPHY | Chief Legal Officer | 29 Jan 2024 | Sale | 2,053 | 17.8005 | 36,544 | D |
| 31 Jan 2024 17:30 | KURA | Kura Oncology Inc | DALE STEPHEN | Chief Medical Officer | 30 Jan 2024 | Sale | 4,825 | 21.5502 | 103,980 | D |
| 31 Jan 2024 17:30 | KURA | Kura Oncology Inc | DALE STEPHEN | Chief Medical Officer | 29 Jan 2024 | Sale | 2,758 | 17.8005 | 49,094 | D |
| 31 Jan 2024 17:30 | KURA | Kura Oncology Inc | DALE STEPHEN | Chief Medical Officer | 29 Jan 2024 | Sale | 4,400 | 17.8005 | 78,322 | D |
| 26 Jan 2024 17:10 | KURA | Kura Oncology Inc | WILSON TROY EDWARD | President and CEO | 24 Jan 2024 | Sale | 6,945 | 20.23 | 140,497 | D |
| 26 Jan 2024 17:10 | KURA | Kura Oncology Inc | WILSON TROY EDWARD | President and CEO | 24 Jan 2024 | Sale | 84,107 | 20.23 | 1,701,485 | D |
| 21 Jun 2023 16:29 | KURA | Kura Oncology Inc | MALLEY THOMAS | Director | 16 Jun 2023 | Purchase | 50,000 | 11.5 | 575,000 | I |
| 31 Jan 2023 17:20 | KURA | Kura Oncology Inc | FORD KATHLEEN | Chief Operating Officer | 27 Jan 2023 | Sale | 1,821 | 13.8901 | 25,294 | D |
| 31 Jan 2023 17:17 | KURA | Kura Oncology Inc | FLOWERS KIRSTEN | CCO & Chief Strategy Officer | 27 Jan 2023 | Sale | 1,906 | 13.89 | 26,474 | D |
| 31 Jan 2023 17:14 | KURA | Kura Oncology Inc | DOYLE THOMAS JAMES | SVP, Finance & Accounting | 27 Jan 2023 | Sale | 866 | 13.8902 | 12,029 | D |
| 31 Jan 2023 17:14 | KURA | Kura Oncology Inc | DOYLE THOMAS JAMES | SVP, Finance & Accounting | 27 Jan 2023 | Sale | 682 | 13.8898 | 9,473 | D |
| 31 Jan 2023 17:10 | KURA | Kura Oncology Inc | DALE STEPHEN | Chief Medical Officer | 27 Jan 2023 | Sale | 4,840 | 13.8686 | 67,124 | D |
| 31 Jan 2023 17:10 | KURA | Kura Oncology Inc | DALE STEPHEN | Chief Medical Officer | 27 Jan 2023 | Sale | 4,385 | 13.8903 | 60,909 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)